These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37957199)

  • 41. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
    Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Pérez de Isla L; Watts GF; Alonso R; Díaz-Díaz JL; Muñiz-Grijalvo O; Zambón D; Fuentes F; de Andrés R; Padró T; López-Miranda J; Mata P
    Eur Heart J; 2021 Jun; 42(22):2201-2211. PubMed ID: 33437997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Screening for familial hypercholesterolemia from low-density lipoprotein cholesterol levels at admission in the coronary care unit].
    Chemaly P; Nallet O; Delarche N; Legagneur C; Boulestreau R; Reibel I; Palette C; Grenier A; Courtade H; Beaune G; Belle L; Georges JL
    Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):300-309. PubMed ID: 30290906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.
    Auckle R; Su B; Li H; Xu S; Xie M; Song Y; Abdul Quddus M; Xu Y; Liu B; Che W
    PLoS One; 2017; 12(10):e0186815. PubMed ID: 29088271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early echocardiographic signs of cardiovascular affection in pediatric familial hypercholesterolemia.
    Ibrahim H; Saad H; Abdelaziz O; Abdelmohsen G
    Eur J Pediatr; 2023 Oct; 182(10):4389-4397. PubMed ID: 37477701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program.
    Danchin N; Farnier M; Zeller M; Puymirat E; Cottin Y; Belle L; Lemesle G; Cayla G; Ohlmann P; Jacquemin L; Perret T; Angoulvant D; Albert F; Ferrières J; Schiele F; Simon T;
    J Clin Lipidol; 2020; 14(3):352-360.e6. PubMed ID: 32527469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
    Escate R; Padró T; Suades R; Camino S; Muñiz O; Diaz-Diaz JL; Sionis A; Mata P; Badimon L
    Cardiovasc Res; 2021 Jan; 117(1):109-122. PubMed ID: 32061123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
    Saavedra YG; Dufour R; Davignon J; Baass A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study.
    Teramoto T; Sawa T; Iimuro S; Inomata H; Koshimizu T; Sakakibara I; Hiramatsu K
    Cardiovasc Ther; 2020; 2020():5936748. PubMed ID: 32636924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients.
    Pérez de Isla L; Alonso R; Argüeso R; Muñiz-Grijalvo O; Álvarez-Baños P; Badimón L; Watts GF; Mata P;
    J Clin Lipidol; 2022; 16(5):733-736. PubMed ID: 35906178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Healthy Lifestyle in Patients With Familial Hypercholesterolemia.
    Tada H; Kojima N; Yamagami K; Nomura A; Nohara A; Usui S; Sakata K; Hayashi K; Fujino N; Takamura M; Kawashiri MA
    JACC Asia; 2023 Feb; 3(1):152-160. PubMed ID: 36873758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Coronary Artery Disease in Young Adults and Assessment of Long-term Outcomes.
    Hassan A; Jaffe R; Rubinshtein R; Karkabi B; Halon DA; Flugelman MY; Zafrir B
    Isr Med Assoc J; 2018 Oct; 20(10):613-618. PubMed ID: 30324777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study.
    Brinck J; Hagström E; Nåtman J; Franzén S; Eeg-Olofsson K; Nathanson D; Eliasson B
    Diabetes Care; 2022 Dec; 45(12):3040-3049. PubMed ID: 36326759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study.
    Sánchez-Ramos A; Fernández-Labandera C; Vallejo-Vaz AJ; Bonacho EC; Quevedo-Aguado L; Catalina-Romero C; Valdivielso P; Sánchez-Chaparro MÁ
    Atherosclerosis; 2021 Dec; 338():39-45. PubMed ID: 34785430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
    Bucholz EM; Rodday AM; Kolor K; Khoury MJ; de Ferranti SD
    Circulation; 2018 May; 137(21):2218-2230. PubMed ID: 29581125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
    Besseling J; Hovingh GK; Huijgen R; Kastelein JJP; Hutten BA
    J Am Coll Cardiol; 2016 Jul; 68(3):252-260. PubMed ID: 27417002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease.
    Zeitouni M; Clare RM; Chiswell K; Abdulrahim J; Shah N; Pagidipati NP; Shah SH; Roe MT; Patel MR; Jones WS
    J Am Heart Assoc; 2020 Dec; 9(24):e017712. PubMed ID: 33287625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.